Blue Circle Health, a 501(c)(3) nonprofit organization dedicated to improving the health of people with type 1 diabetes (T1D), announced the expansion of its T1D telehealth care, education, ...

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the secon ...

We’ve been in the 2000s for a quarter century now. That’s a long time, and over these past 25 years, the world has changed a ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Convatec reported a 7.7% rise in organic revenue for the period ending October 30, outpacing its initial full-year target ...